Cardiac Resynchronization Therapy Pacemaker Market Size, Share, Analysis and Forecasts 2016 - 2020
- Submitted by: Marketreport
- Views: 49
- Category: Other
- Date Submitted: 07/20/2016 09:04 PM
- Pages: 4
- Report this Essay
Technavio Announces the Publication of its Research Report Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market:
BIOTRONIK, Boston Scientific, LivaNova, Medtronic, and St. Jude Medical.
Commenting on the report, an analyst from Technavios team said: Popularity of robot-assisted cardiac surgery is a key trend in the market. Robotic technology provides physicians with a better view of the operative field and easy movement of instruments with precision and control within close-fitting spaces. These surgeries help reduce the duration of hospital stays, facilitating better cost management. These procedures also prevent human errors and ensure improved outcomes, reduced recovery periods, and minimal pain and discomfort.
Browse full report with TOC@ https://marketreportscenter.com/reports/328682/global-cardiac-resynchronization-therapy-pacemaker-market-2016-2020
According to the report, there is an increase in the incidence of cardiovascular diseases. Cardiovascular diseases such as heart attack, coronary artery disease, cardiomyopathy hypertension, heart arrhythmias, and congenital heart defects can cause heart failures. The incidence of these diseases is rising, with sudden cardiac arrest being the leading cause of death worldwide among people aged above 40.
Further, the report states that there is a high risk of potential complications in the implantation of CRT-Ps. Implantation of CRT-Ps at an advanced age is associated with a high probability of mortality. Some other complications related to CRT-Ps include allergic or physiologic reactions, infections, lead erosion or migration, lead breakage, hematoma or seroma, inaccurate or inability to provide pacing, lead tip deformation, component failure, and inappropriate detections due to diaphragmatic myopotential oversensing.
The study was...
Technavio recognizes the following companies as the key players in the Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market:
BIOTRONIK, Boston Scientific, LivaNova, Medtronic, and St. Jude Medical.
Commenting on the report, an analyst from Technavios team said: Popularity of robot-assisted cardiac surgery is a key trend in the market. Robotic technology provides physicians with a better view of the operative field and easy movement of instruments with precision and control within close-fitting spaces. These surgeries help reduce the duration of hospital stays, facilitating better cost management. These procedures also prevent human errors and ensure improved outcomes, reduced recovery periods, and minimal pain and discomfort.
Browse full report with TOC@ https://marketreportscenter.com/reports/328682/global-cardiac-resynchronization-therapy-pacemaker-market-2016-2020
According to the report, there is an increase in the incidence of cardiovascular diseases. Cardiovascular diseases such as heart attack, coronary artery disease, cardiomyopathy hypertension, heart arrhythmias, and congenital heart defects can cause heart failures. The incidence of these diseases is rising, with sudden cardiac arrest being the leading cause of death worldwide among people aged above 40.
Further, the report states that there is a high risk of potential complications in the implantation of CRT-Ps. Implantation of CRT-Ps at an advanced age is associated with a high probability of mortality. Some other complications related to CRT-Ps include allergic or physiologic reactions, infections, lead erosion or migration, lead breakage, hematoma or seroma, inaccurate or inability to provide pacing, lead tip deformation, component failure, and inappropriate detections due to diaphragmatic myopotential oversensing.
The study was...